Beth Seidenberg
Westlake Village BioPartners Managing Director
location
San Francisco, California
investment range
$100k - $25.0m
sweet spot
$10.0m
Beth Seidenberg's Past Investments (37)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Tmunity Therapeutics | Series B | $75M | Oct 2019 | |
| Trucode Gene Repair | Venture Round | $34M (Lead) | Sep 2019 | |
| Tmunity Therapeutics | Series A | $35M | Apr 2018 | |
| Expansion Therapeutics | Series A | $55.3M (Lead) | Jan 2018 | |
| ARMO BioSciences | Series C | $67M | Aug 2017 | |
| Progyny | Series B | $10M | May 2017 | |
| Progyny | Series B | $14.7M | Jul 2016 | |
| TESARO | Post-IPO Equity | $155M (Lead) | Mar 2016 | |
| ARMO BioSciences | Series C | $50M | Feb 2016 | |
| Hixme | Series A | $3.1M (Lead) | Jan 2016 |
Beth Seidenberg's Media
No media found for Beth Seidenberg.